Evidence map›Paper›PMID 34178724›Full record

ReviewFrontiers in cellular and infection microbiology2021

Targeting SUMOylation in

Daffiny Sumam de Oliveira, Thales Kronenberger, Giuseppe Palmisano, Carsten Wrenger, Edmarcia Elisa de Souza

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Identification ofFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Daffiny Sumam de OliveiraDepartment of Parasitology, Institute of Biomedical Sciences at the University of São Paulo, São Paulo, Brazil.
Thales KronenbergerDepartment of Internal Medicine VIII, University Hospital Tübingen, Tübingen, Germany.
Giuseppe PalmisanoDepartment of Parasitology, Institute of Biomedical Sciences at the University of São Paulo, São Paulo, Brazil.
Carsten WrengerDepartment of Parasitology, Institute of Biomedical Sciences at the University of São Paulo, São Paulo, Brazil.
Edmarcia Elisa de SouzaDepartment of Parasitology, Institute of Biomedical Sciences at the University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRUniversity Children's Hospital Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria is a parasitic disease that represents a public health problem worldwide. Protozoans of the

Indexed as

AntimalarialsMalariaPlasmodiumAnimalsHumansPlasmodium falciparumSumoylationAntimalarialsdrug targetmalariaPlasmodium falciparumSUMOSUMOylation

Identifiers

PMID34178724
PMCPMC8224225
OpenAlexW3171191322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.